Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Centenary Institute
Street 1: Building 93, Royal Prince Alfred Hospital
Street 2: Misseden Road
City: Camperdown
Province: New South Wales
Post Code: 2050
Country: Australia
Phone: +61 2 9565 6100
Email: b.saunders@centenary.org.au
Web Site: http://www.tb.org.au/ also www.centenary.org.au

Focal Point Contact Information

Salutation: Ms
First Name: Karen
Last Name: McBrien
Title: Manager Special Projects
Email: k.mcbrien@centenary.org.au
Phone: +61 2 9565 6100

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Bernadette
Last Name: Saunders
Title: Group Head: Host Response to Infection, Tuberculosis Research Program
Email: b.saunders@centenary.org.au
Phone: +61 2 9565 6100

General Information

Board Constituency: Technical agencies
Organization Type - Primary: Academic / Research Institution
Organization Type - Secondary: None
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
The Centenary Institute conducts basic medical research into cancer, cardiovascular disease and infectious diseases. The Centenary Institute houses the largest tuberculosis (TB) research group in Australia and we are the only facility in the country permitted to work with experimental tuberculosis infection. We have a team of 23 dedicated researchers, headed up by Professor Warwick Britton. Our researchers work on various TB projects to improve the knowledge of MTB and ultimately develop methods, tests, vaccines and drugs to control TB.

We have developed a partnership with the National Lung Hospital in Hanoi, Vietnam. We are currently carrying out two key research projects with the NLH including analysing blood samples to identify genetic susceptibility and a public control study to screen people in households where someone has TB.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 11 - 25
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 6 - 10
 
What is your organization's annual budget (USD) dedicated to TB? $1 MIL-$10 MIL
How did you hear about the Stop TB Partnership: World TB Day
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
The Centenary Institution is lead institute for a recently awarded centre of Research Excellence for Tuberculosis Control in Australia. A number of the investigators on this are members of State and National Committees responsible for recommending and implementing National TB Control Plan.
 

Geographical Reach

Which country is your headquarters located in: Australia
Which WHO region is the main focus of your work: South East Asian
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Australia
Viet Nam

Specializations

Advocacy
Research and Development
Technical Assistance

Specializations in Countries

Research and Development Australia
Research and Development Viet Nam

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Collaborative project on enhanced case detection in Vietam

Drug-Resistant TB:
Monitoring drug resistance in Australia with new molecular tools

Laboratory Strengthening:
Transfer of new technologies to laboratories in Vietnam

New TB Drugs:
Basic research on structure based drug design for TB

New TB Vaccines:
Extensive program in development and testing of new T vaccines

Fundamental Research:
Basic studies on immunological control of TB in humans and animal models and immunogenetics.

Research:
Operational studies in Vietnam

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: March 14, 2011
Last updated: June 17, 2014